Auxilium promotes James Tursi to CMO
This article was originally published in Scrip
Executive Summary
Auxilium Pharmaceuticals, a speciality biopharmaceutical company, has named Dr James Tursi chief medical officer, reporting to Armando Anido, CEO and president. Dr Tursi has worked for Auxilium since March 2009, responsible for overseeing clinical development, clinical operations, biometrics and medical writing. Prior to Auxilium, he served as a medical director for Procter and Gamble Pharmaceuticals.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.